Oral delivery of microparticles containing plasmid DNA encoding hepatitis-B surface antigen (Q39395958)

11 September 2017

title

Oral delivery of microparticles containing plasmid DNA encoding hepatitis-B surface antigen (English)

1 reference

11 September 2017

Tuhin Bhowmik

1 reference

11 September 2017

Bernadette D'Souza

series ordinal

1 reference

11 September 2017

Mohammad N Uddin

series ordinal

1 reference

11 September 2017

Martin J D'Souza

series ordinal

1 reference

11 September 2017

publication date

18 February 2012

1 reference

Journal of Drug Targeting

11 September 2017

published in

1 reference

11 September 2017

1 reference

11 September 2017

1 reference

11 September 2017

page(s)

364-371

1 reference

Hepatitis B virus immunopathogenesis

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.662686

DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.662686

Further protection against antigenic drift of influenza virus in a ferret model by DNA vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.662686

Oral DNA vaccination in utero induces mucosal immunity and immune memory in the neonate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.662686

Fetal immunization by a DNA vaccine delivered into the oral cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.662686

Toward the global elimination of hepatitis B virus transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.662686

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.662686

Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.662686

Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.662686

Induction of Th1 type response by DNA vaccinations with N, M, and E genes against SARS-CoV in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.662686

Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.662686

Establishment and primary application of a mouse model with hepatitis B virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.662686

Hepatitis B virus-induced oncogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.662686

Perspectives on mucosal vaccines: is mucosal tolerance a barrier?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.662686

The development of vaccines against SARS corona virus in mice and SCID-PBL/hu mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.662686

Exposing the immunology of naked DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.662686

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.662686

Genetic immunization is a simple method for eliciting an immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.662686

Heterologous protection against influenza by injection of DNA encoding a viral protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.662686

Skeptical scientists skewer VaxGen statistics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.662686

Live attenuated HIV vaccines: pitfalls and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.662686

M cell-targeted DNA vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.662686

A crucial role of macrophages in the immune responses to oral DNA vaccination against hepatitis B virus in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.662686

Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.662686

Induction of lymphocytes activated marker CD69 following exposure to chitosan and alginate biopolymers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.662686

Intranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and CTL responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.662686

10.3109/1061186X.2012.662686

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference